TUTORIALSNov 12, 2026 · 1 min read
Argus Research Maintains Buy on Amgen, Raises Price Target to $515
By Benzinga Newsdesk
Argus Research analyst Jasper Hellweg maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $460 to $515.
Share this article
Keep reading.
Trade what
you just read.
Apply the analysis on a live or demo account, same execution, no risk on demo.
Your seat at the market is ready.
Open your account in minutes, transparent pricing, fast withdrawals and support that answers.



